Fig. 1 | Scientific Reports

Fig. 1

From: Cardamonin inhibits the growth and stemness of osteosarcoma stem cells by inducing autophagy and inhibiting the Wnt/β-catenin signaling pathway

Fig. 1

Impact of CDN on Cell Viability in Various Osteosarcoma Cells: Cell survival was evaluated using the CCK8 assay 24 and 48 h post-CDN treatment. (A) Molecular Composition of CDN. Various concentrations of CDN (0,0.625, 1.25, 2.5, 5, 10, 20, 40 microns) were used to treat MG63 (B), 143 B (C), U2OS (D), HOS (E), and SAOS2 (F) osteosarcoma cell lines. Cell viability ratio was assessed at 24 and 48 h after treatment. The control group (0 μM) did not receive CDN treatment, and cell viability remained at 100%. * p < 0.05; *** p < 0.001 vs. the un-treated control.

Back to article page